The DOI matches its Crossref record.
AI in small-molecule drug discovery: a coming wave?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The impact of big data and AI in drug discovery, the subject of a 2020 review in this journal (4), continues to attract significant interest: Investors (5, 6), industrial (7, 8) and academic scientists (9, 10), and legislators (https://bit.ly/40LRAip) discuss the impact of AI for drug discovery (AI4DD).”
From Artificial Intelligence for Drug Discovery: Are We There Yet? (2024) · cites this paper as [5]
Citations
Cited by
Sorted by citations
Items 101–183 of 183
MHNfs: Prompting In-Context Bioactivity Predictions for Low-Data Drug Discovery
Schimunek, J., Luukkonen, S., & Klambauer, G. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c02373 · Cited by 7
Effectively utilizing publicly available databases for cancer target evaluation
Croft, D. R., Lodhia, P., Lourenco, S. D. S., & MacKay, C. (2023) · NAR Cancer · doi:10.1093/narcan/zcad035 · Cited by 7
Unlocking DCAFs To Catalyze Degrader Development: An Arena for Innovative Approaches
Miao, Q., Kadam, V. D., Mukherjee, A., Tan, Z., & Teng, M. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01209 · Cited by 7
Application and Prospects of Large Language Models in Small-Molecule Drug Discovery
Ma, J., Liu, J., Xu, D., Song, X., & Zhang, Z. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c04083 · Cited by 9
L’intelligence artificielle, une révolution dans le développement des médicaments
Moingeon, P. E., Garbay, C., Dahan, M., Fermont, I., Benmakhlouf, A., Gouyette, A., Poitou, P., Saint-Pierre, A., & pharmaceutiques, L. G. D. V. I. E. S. (2024) · médecine/sciences · doi:10.1051/medsci/2024028 · Cited by 7
Visual analysis of drug research and development based on artificial intelligence
Wei, W., Song, C., Qi, C., Zhang, X., Zhang, X., Pu, R., & Ao, Y. (2024) · Journal of Holistic Integrative Pharmacy · doi:10.1016/j.jhip.2024.12.002 · Cited by 5
Precision oncology in the age of AI: lessons from AI-driven drug discovery and clinical translation
Yoo, W. (2026) · BJC Reports · doi:10.1038/s44276-026-00221-1 · Cited by 6
Flash optimization of drug combinations for Acinetobacter baumannii with IDentif.AI-AMR
You, K., Yazid, N. B. M., Chong, L. M., Hooi, L., Wang, P., Zhuang, I., Chua, S. J., Lim, E., Kok, A. Z. X., Marimuthu, K., et al. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00079-2 · Cited by 6
AI Assistance in the Drug Development Process: Reaching for a Regulatory Framework
Giaramita, H. (2024) · Seton Hall Law Review · doi:10.60095/wbyz9142 · Cited by 4
Pan, Y., Cai, H., Ye, F., et al. (2025) · Aging Cell · doi:10.1111/acel.70116 · Cited by 4
Data science in pharmaceutical R&D: the DISRUPT-DS industry roundtable
Khan, N. S., Senderovitz, T., Weatherall, J. H., Branson, J., Egersdoerfer, B., Genevois-Marlin, E., Jasti, S., Kazi, M., Kumble, R., Loerch, P., et al. (2024) · Nature Reviews Drug Discovery · doi:10.1038/d41573-024-00104-5 · Cited by 5
Self-citationDrug Discovery and Development Processes
Selvakumar, P., Seenivasan, S., Jadhav, R., et al. (2024) · Advances in healthcare information systems and administration book series · doi:10.4018/979-8-3693-6577-9.ch011 · Cited by 4
Chemistry and Technology Innovation to Advance Green and Sustainable Chemistry
Prabhakaran, P., Bhardwaj, S., Chopra, B., Dhingra, A. K., & Kant, M. (2024) · Wiley eBooks · doi:10.1002/9781394212767.ch12 · Cited by 4
Generative AI in pharmaceutical R&D: From large language models to AI agents to regulation
Weatherall, J., & Meier, C. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104593 · Cited by 4
Self-citationMalothu, R. M., & Thalari, G. (2025) · ChemistrySelect · doi:10.1002/slct.202404621 · Cited by 3
The Six Ds of Exponentials and drug discovery: A path toward reversing Eroom’s law
Tropsha, A., Martin, H., & Cherkasov, A. R. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104341 · Cited by 5
Editorial: Insights in silico methods and artificial intelligence for drug discovery: 2022
Medina‐Franco, J. L. (2023) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2022.1126955 · Cited by 3
da Silva, R. G. L. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4672439 · Cited by 3
Artificial intelligence in small-molecule drug discovery
Martinelli, C., Repetto, M., & Curigliano, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13671-9.00012-0 · Cited by 3
Wang, D. D., & Huang, Y. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013074 · Cited by 2
What patents on AI-derived drugs reveal
Freilich, J., & Rai, A. K. (2025) · Science · doi:10.1126/science.adw1972 · Cited by 3
Durojaye, O. A., Bellah, S. F., Uzoeto, H. O., Okoro, N. O., Cosmas, S., Ajima, J. N., Arazu, A. V., Ezechukwu, S. P., Ezechukwu, C. S., & Odiba, A. S. (2025) · Journal of Molecular Modeling · doi:10.1007/s00894-025-06480-y · Cited by 3
Deep learning for small-molecule drug discovery: From molecular design to clinical translation
Oliveira, R. I., Pereira, T., Abbasi, M., Salvador, J. A. R., & Arrais, J. P. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101533 · Cited by 4
India's Drug Discovery and Development Industry: The Quest for Novel Therapeutic Treatments
Differding, E. (2026) · ChemMedChem · doi:10.1002/cmdc.70304 · Cited by 2
Pediatric Sarcomas: The Next Generation of Molecular Studies
Giannikopoulos, P., & Parham, D. M. (2022) · Cancers · doi:10.3390/cancers14102515 · Cited by 4
Hey, T. (2023) · OECD eBooks · doi:10.1787/7b7b1bce-en · Cited by 4
Yıldırım, M., & Çeli̇k, İ. (2024) · Biomedical engineering · doi:10.5772/intechopen.1004804 · Cited by 2
Mining Medicinally Relevant Bioreduction Substrates Inspired by Ligand-Based Drug Design
Rago, A. J., Zoi, I., Gartman, J. A., McDaniel, K. A., Jana, N., Liu, D., & Bai, W. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01129 · Cited by 2
Atom-Level Quantum Pretraining Enhances the Spectral Perception of Molecular Graphs in Graphormer
Fallani, A., Arjona-Medina, J. A., Chernichenko, K. Y., Ирекович, Н. Р., Wegner, J. K., & Tkatchenko, A. (2024) · Lecture notes in computer science · doi:10.1007/978-3-031-72381-0_7 · Cited by 2
Rampant proteolysis at the intersection of therapy-induced hypoalbuminemia and acute pancreatitis
Leonard, S.-E., Kenis, P. J. A., & Perkins, R. C. (2022) · 4open · doi:10.1051/fopen/2022011 · Cited by 2
Lessons from shortcomings in machine learning for medical imaging
Varoquaux, G. P., & Cheplygina, V. (2023) · OECD eBooks · doi:10.1787/b885eecd-en · Cited by 2
DDE KG Editor: A data service system for knowledge graph construction in geoscience
Hou, C., Liu, K., Wang, T., Shi, S., Yan, L., Zhu, Y., Hu, X., Wang, C., Zhou, C., & Lv, H. (2024) · Geoscience Data Journal · doi:10.1002/gdj3.245 · Cited by 3
The usage of transcriptomics datasets as sources of Real-World Data for clinical triallingPreprint
Matos‐Filipe, P., García‐Illarramendi, J. M., Jorba, G., Oliva, B., Farrés, J., & Mas, J. M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.10.515995 · Cited by 4
Huang, D., Zhao, C., Li, R., Yao, N., Xu, J., & Gu, Q. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00909 · Cited by 1
Experimental Assays: Chemical Properties, Biochemical and Cellular Assays,and In Vivo Evaluations
Serafim, M. S. M., Reis, E. V. D. S., Coelho-dos-Reis, J. G. A., Abrahão, J. S., & O’Donoghue, A. J. (2024) · Computer-aided drug discovery and design · doi:10.1007/978-3-031-76718-0_12 · Cited by 1
High-Throughput Techniques in Radiochemistry
Bowden, G. D., Lu, Y., Jones, J., van Dam, R. M., Pascali, G., & Scott, P. J. H. (2025) · Springer eBooks · doi:10.1007/978-3-031-84632-8_18 · Cited by 1
Agbaglo, D. A., Ho, M. T. N., Frisch, M. J., et al. (2025) · The Journal of Physical Chemistry A · doi:10.1021/acs.jpca.5c01484 · Cited by 1
Artificial Intelligence and Cancer Immunotherapy
Shah, A., Bhat, A. A., Bhat, M. R., Assad, A., & Macha, M. A. (2025) · Springer eBooks · doi:10.1007/978-981-96-8176-1_16 · Cited by 1
Hao, Y., Li, B., Huang, D., et al. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02040 · Cited by 1
Artificial Intelligence at Seventy: From Symbolic Aspirations to Emergent Realities
Ochoa-Barragán, R., Raya-Tapia, A. Y., López-Flores, F. J., Márquez, C. R., & Ponce‐Ortega, J. M. (2026) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.5c04476 · Cited by 1
Leveraging artificial intelligence in tissue regenerative engineering via small-molecule libraries
Hosseini, F. S., Whitfield, T., Mitchell, J., Li, Y., & Lo, K. W. ‐. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104623 · Cited by 2
Antibacterial drug discovery: challenges and preclinical promises from synthetic small molecules
Fernandes, G., Kim, S., dos Santos, J. L., Wang, Y., Soudy, C., Redmond, J. M., Castagnolo, D., & Todd, M. H. (2026) · Chemical Society Reviews · doi:10.1039/d5cs00617a · Cited by 4
Advancing Antiviral Design: Integrating Natural Products, Computation and Targeted Delivery
Lanrewaju, A. A., Enitan, A. M., Sabiu, S., & Swalaha, F. M. (2026) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70365 · Cited by 2
Mi, C.-L., Liu, J., Wang, X., Shang, J., Zhu, R., Wang, J., & Dai, L.-Y. (2024) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm62325.2024.10822460 · Cited by 2
Ai-Driven Discovery of Brain-Penetrant Galectin-3 Inhibitors for Alzheimer's Disease TherapyPreprint
Ye, Z., Liu, X., Xu, J., Zheng, S., Zhong, J., Yang, Y., Xie, Y., Zhang, H., Chen, J., Dai, C., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5144196 · Cited by 1
Data Science for Analytical Development and Quality Control
Bodiwala, K. B., Lalwani, R., Jain, Z., & Gajjar, A. K. (2025) · Wiley eBooks · doi:10.1002/9781394287383.ch11 · Cited by 1
Wu, X., Xie, Y., Zhao, K., & Lü, J. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2022.12.007
Tourassi, G. D., Shankar, M. A., & Wang, F. (2023) · OECD eBooks · doi:10.1787/0e1b4c2f-en
Eroom’s Law and the decline in the productivity of biopharmaceutical R&D
Scannell, J. W. (2023) · OECD eBooks · doi:10.1787/6f256d17-en
The end of Moore’s Law? Innovation in computer systems continues at a high pace
Kressel, H. (2023) · OECD eBooks · doi:10.1787/63e48242-en · Cited by 1
Quantifying the “cognitive extent” of science and how it has changed over time and across countries
Milojević, S. (2023) · OECD eBooks · doi:10.1787/1f717652-en
Interpretability: Should – and can – we understand the reasoning of machine-learning systems?
Cartwright, H. (2023) · OECD eBooks · doi:10.1787/2d0478b9-en
OECD (2023) · OECD eBooks · doi:10.1787/f1262928-en
Wird KI neue Medikamente gegen Herzkrankheiten hervorbringen?
Glaser, M., Ritterhoff, J., Most, P., & Wade, R. C. (2023) · Aktuelle Kardiologie · doi:10.1055/a-2131-2843
Computational drug discovery and design
Anika, M., & Ariyanto, Y. S. (2023) · Crystallography Reviews · doi:10.1080/0889311x.2023.2281998
Beyond the Hype: The Reality of Implementing AI to Drive Drug Discovery Success
Segall, M. (2024) · GEN Biotechnology · doi:10.1089/genbio.2024.0042
The path to adoption of open source AI for drug discovery in Africa
Turón, G., & Duran‐Frigola, M. (2024) · Artificial Intelligence in the Life Sciences · doi:10.1016/j.ailsci.2024.100118 · Cited by 1
FraHNN: A Fragment-Based Hypergraph Neural Network Model for Molecular Property Prediction
Liu, Z., Zhao, Y., Zhang, H., He, S., Bo, X., & Zan, P. (2024) · Communications in computer and information science · doi:10.1007/978-981-96-0188-2_22
AI-driven antimicrobial peptides for drug development
Arora, Y., Lalwani, H., Kumar, A., Mathur, P., Chaturvedi, N., & Mishra, V. (2025) · Methods in microbiology · doi:10.1016/bs.mim.2024.08.003
Kim, J., & Choi, J. (2025) · The Journal of Supercomputing · doi:10.1007/s11227-025-07406-4
Song, D. (2025) · Journal of Diseases and Medicinal Plants · doi:10.11648/j.jdmp.20251102.13
AI in Medicine Recent Progress Opportunities and Future Directions
Sodiqovna, I., & Park, J. C. (2024) · International Conference on Future Networks and Distributed Systems (ICFNDS) · doi:10.1145/3726122.3726267
A Personalized and Preventive Medicine
Moingeon, P. E. (2025) · Springer eBooks · doi:10.1007/978-3-031-91668-7_9
Moingeon, P. E. (2025) · Springer eBooks · doi:10.1007/978-3-031-91668-7_7
The Potential of Generative AI in Drug Development
Gupta, D., Sudhakar, R., Mujawar, S. S., Kadam, R., Patil, V., Kumar, A., Ahire, P., & Gupta, K. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-2043-4.ch005
Inoue, T., & Yuki, S. (2024) · Japanese Journal of Pesticide Science · doi:10.1584/jpestics.w24-30
Xu, Y. (2025) · International Conference on Educational Digitalization and Computer Science in the Guangdong-Hong Kong-Macao Greater Bay Area · doi:10.1145/3746469.3746569
Singh, R., Pandey, P., Kumar, A., & Mishra, M. K. (2025) · Current Bioinformatics · doi:10.2174/0115748936370246250903052830
Challenges and Future Directions in Al for Drug Discovery
Zhang, J., Shao, X., & Fan, X. (2026) · Springer eBooks · doi:10.1007/978-3-031-98022-0_27
Drug discovery in plastic surgery
Tang, Y., Wang, J., & Wong, A. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-91168-9.00103-4
Function-Driven Molecular Design Enabled by Instruction-Tuned Large Language ModelsPreprint
Yang, Q., Wang, X., Wang, Y., Zhu, R., Li, H., Wu, X., Zhang, X., Zhou, M., Pu, H., Cai, K., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8819034/v1
Site-specific photosensitizer conjugation and anti-viral application of protein targeting SARS-CoV-2
Jiang, Y., Zou, C., Zhu, S., Fang, X., Zhang, X., Zhou, X., & Huang, M. (2026) · Dyes and Pigments · doi:10.1016/j.dyepig.2026.113660
Ahmadi, S. A., Razavi, R., & Tajaldini, H. (2026) · Journal of Chemistry · doi:10.1155/joch/8437866
From Research to Impact: A Comprehensive Platform for AI Model Deployment in Drug Discovery
Koletou, E., Mu, L., Stoyanova, R., Muñoz, J. O. G., Kozieł, K., Cisło, P., Maffioli, L., Adamczyk, D., Witkowski, J., Bartosik, M., et al. (2026) · Artificial Intelligence in the Life Sciences · doi:10.1016/j.ailsci.2026.100171
AI-Driven Innovations in Pulmonary Medicine
Aminabee, S. (2026) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3373-7759-9.ch011
Clarke, R., Palazzo, G., Ruzicka, J., Ferla, S., & Bassetto, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1866562
Artificial Intelligence and Other Emerging Technologies for Radiopharmaceutical Development
Bowden, G. D., Webb, E., Jackson, I. M., James, M. L., & Scott, P. J. H. (2026) · Springer eBooks · doi:10.1007/978-3-032-26476-3_36
Abdulkarim, M., Bawazir, W., Issa, A. A., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19071070
Thinking about the Impact of Artificial Intelligence on U.S. Health Care Costs and Spending Growth
Kocher, B., Zhao, B., & Duffy, E. L. (2026) · NEJM Catalyst · doi:10.1056/cat.25.0509 · Cited by 1
Role of AI and Machine Learning in Designing Next-Generation Therapeutics
Kaushik, A., Verma, G., Bharadava, K., Kumar, S., & Kaushal, R. S. (2026) · Springer eBooks · doi:10.1007/978-981-92-0477-9_17
Reassessing R&D outcomes of leading pharmaceutical companies
Schuhmacher, A., Witting, M., Hartl, D., Hinder, M., & Gassmann, O. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104763
Xu, J., Bai, H., & Hu, L. (2026) · MedComm – Future Medicine · doi:10.1002/mef2.70070
Korutla, R., Garg, T., Pol, S. S., Shivandi, V., Gnanam, S., Padari, K. S., & Amal, S. (2026) · Artificial Intelligence in the Life Sciences · doi:10.1016/j.ailsci.2026.100183 · Cited by 1
Metadata
- Authors
- Jayatunga, M. K. P., Xie, W., Ruder, L., Schulze, U., & Meier, C.
- Affiliations
- Boston Consulting Group (United States) (US)
- Corresponding author
- Meier, Christoph
- Venue
- Nature Reviews Drug Discovery
- Published
- 2022-02-07
- Volume
- 21
- Issue
- 3
- Pages
- 175-176
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W4210852924
- Cited by
- 187
- References
- 0
- Citations by year
- 2026: 29 · 2025: 56 · 2024: 48 · 2023: 42 · 2022: 12
- FWCI
- 21.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- artificial intelligence, small molecule drug discovery, machine learning, drug design
- MeSH terms
- Artificial Intelligence, Humans, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review